A Busy Weekend
This weekend, our President and Scientific Director, Douglas Lewis, Executive Vice President Veronica Lewis and Marketing Communications Manager, Nancy Parra attended the IPN/PRN meeting at the Ritz Carlton on Amelia Island, Florida. They connected with old friends and spoke about our latest alcohol biomarker tests and the science behind them. The meeting went well with many local associations and treatment centers interested in our materials and tests. Their goal is to help their clients. Our tests give them objective answers to difficult questions.
At the same time, our Clinical Projects Manager, Bob Demaree exhibited at the Interventions in Neo Care conference in Las Vegas. Bob met with old friends and new and discussed our latest assay the CordStat® EtOH that tests for an alcohol biomarker in umbilical cord tissue. The presence of this biomarker can mean that the mother had risky alcohol behavior in the last weeks of her pregnancy.
If you met with us, and even if you didn’t, and have any questions please call us at 800-235-2367. We will be happy to help.https://www.usdtl.com/blog/a-busy-weekend
Bob Demaree, Clinical Projects Manager at USDTL is at The Fetus & Newborn: State-of-the-Art Care conference in Las Vegas, NV this week. He welcomes every attendee to stop by and learn more about our newborn testing. More importantly our newest assay which can measure an alcohol biomarker in umbilical cord tissue.
Fetal alcohol exposure has been recognized as the leading cause of preventable mental retardation and birth defects. Each year in the United States approximately 40,000 alcohol exposed newborns are diagnosed with Fetal Alcohol Spectrum Disorder. This condition can result in a variety of physical, behavioral and learning disorders. A recent SAMHSA survey reviewing data collected in 2009-2010 reported that 4.7 percent of pregnant women admitted binge or heavy drinking. Early identification is a key factor to improving outcomes for this group. Currently, identification relies on maternal
self-report or the presence of a set of unique physical characteristics. Self-report has limited value in determining alcohol exposure and the physical characteristics may not appear until later in child’s development.
A positive result from our CordStat EtOH is an indication of risky alcohol drinking behavior in the last two to four weeks of pregnancy.
To find out more call customer serivce at 800.235.2367.https://www.usdtl.com/blog/the-fetus-newborn-state-of-the-art-care
October 31st, 2011, The American Academy of Pediatrics sets a new policy telling doctors that screening for drug/alcohol use should be a routine part of a teen’s regular doctors visits –http://bit.ly/roWQux
My question is, if adults lie to their healthcare providers about their alcohol and drug use, why wouldn’t teens? Why not recommend an unbiased-test based on a hair or nail sample. This would give pediatricians a solid factual history to help improve the health of their patients.
We offer a wide variety of hair and nail testing that can identify actual use or misuse and possibly save a life.
Check out our website: https://www.usdtl.com/ for more information.https://www.usdtl.com/blog/american-academy-of-pediatrics-new-policy
Our fabulous staff, including our knowledgable toxicologists President Douglas Lewis and Vice President Laboratory Services, Joseph Jones, are at Booth #2108 to discuss our latest research in alcohol biomarkers and our new CordStatEtoh test.
Also there are fabulous Forensic Account Executive, Patrick Lavelle, and Sales Associate and all around Girl Friday, Victoria Lewis.
Stop by and say hi!
Follow us on twitter @USDTL Hashtag #APHA
“Like” us on Facebook www.facebook.com/USDTL
Partnering with USDTL for Professional Health Services
We care for the Health and Well-being of Healthcare Professionals
Healthcare professionals’ health and well-being is a prerequisite for quality healthcare. USDTL provides partnership opportunities for Health Service Organizations to develop customized tests for screening and monitoring their members. These tests provide HSOs with detailed information to help achieve their goal of improving the lives of those in the healthcare community.
Who We Are:
Established in 1991 as a specialty drug testing facility, USDTL quickly became a leader in the drug testing industry. Our laboratory has an aggressive research and development program and has made significant breakthroughs in the field of analytical toxicology by developing procedures to provide workplace and rehabilitation drug testing using hair and nail specimens. USDTL’s research activities are funded largely by agencies within the National Institutes of Health. We offer specialty, customizable, drug testing for a variety of clinical and research customers, including hospitals, reference laboratories,universities and court systems.
USDTL is continually developing new methods to improve test panels.
Our services go beyond providing alcohol and drug testing results. Businesses, physician health programs, and government agencies depend upon us for drug and alcohol monitoring. University research groups look to us to help meet their research needs. In all these areas, we provide complete analytical testing solutions.
Douglas Lewis, President, and Joseph Jones, Vice President of Laboratory Operations, have over 40 years of experience in forensic toxicology between them and are available to answer questions regarding reported results. Sharing forensic toxicology knowledge is considered an essential part of USDTL customer service.
What We Do:
We offer cutting edge testing for Alcohol Use Detection and Substances of Abuse Monitoring. We provide client services worldwide for healthcare facilities, child protection agencies, the U.S. government, legal services, rehabilitation and treatment centers, businesses and other clinical and forensic laboratories. We partner with organizations; such as, universities and government agencies, to assist with their research projects. USDTL is certified by the College of American Pathologists (CAP) and the New York State Department of Health.https://www.usdtl.com/blog/partnering-with-usdtl-for-professional-health-services
USDTL has been on the cutting edge of substances of abuse testing since 1991. Our goal is to screen for addiction to save a life.
As one Doctor said at the ASA, “Too bad Michael Jackson didn’t take your test. He might be alive today.”
This week Newsweek Magazine ran an article on how dangerously addictive propofol can be.
Newsweek Magazine tells the why and how propofol (the drug they think helped kill the King of Pop) can be dangerously addictive.
Another headline of note that came out this week: Benzodiazepine abuse accounts for almost one third of the emergency room visits in America. Benzodiazepine abuse is the most common prescription drug abused and is involved in one-quarter of all suicide attempts.
USDTL is here to help. Helping to save lives is our mission. Researching future assays in drug and alcohol screening is our vision. Visit https://www.usdtl.com/ for more information.https://www.usdtl.com/blog/in-the-news-this-week
Doug Lewis showing off the booth.
Doug and Victoria welcoming conference goers.
Jessica Droze Program Director of Greenberg and Sucher , Victoria Lewis and Nancy Parra. The female faces of USDTL at the ASA show.
Our Booth back drop.
Our side banners.
Victoria Lewis ready to welcome conference goers on Friday.
Patrick Lavelle, our Forensic Account Executive proud of our booth.
Having a great time sharing our story and our testing and addiction program solutions.https://www.usdtl.com/blog/asa-show-at-mccormick-place
Saturday, Oct 8th The Chicago Tribune ran an article entitled: “Proposal to test Lake Zurich High athletes for drugs divides parents: Critics say such programs violate rights; supporters say they save lives.”
The reporter, Lisa Black, spoke about the protestations from parents over privacy rights but schools have historically used random drug testing on students in extracurricular activities. Time and again testing has been shown to improve outcomes. Today they test using hair samples. According to the article:
“Hair samples check for five illegal drugs, which can be detected up to 90 days after use. The school administers about 1,350 tests annually, spending $65 on each— costs covered by tuition…”
This is a basic test panel in use for years. Current testing available includes over 14 types of drugs plus EtG an alcohol biomarker found in hair and nails that can not only detect use, but can detect the difference between binge drinking and social drinking– something that, according to the article, was of concern to parents and administrators alike.
As a local company we specialize in testing children/adults (using nails, hair, blood, oral fluid and urine) and newborns (through umbilical cord tissue and meconium) for exposure to substances of abuse and alcohol. It is our mission to help identify problems early on so that physicians, parents and courts can help lower Fetal Alcohol Spectrum Disorder symptoms as well as catch and possibly reverse addiction problems in teens and adults.
For more information feel free to call Patrick Lavelle, Forensic Account Executive, USDTL, Inc. at 847-375-0770 and check our website: https://www.usdtl.com/
You can read the full article here.https://www.usdtl.com/blog/school-districts-random-drug-test-using-hair-can-these-tests-be-improved
Two days after the press release announcing our new CordStat EtOH assay, USDTL serves it’s first client testing umbilical cord for alcohol biomarkers. Welcome CordStat EtOH customers:
Our press release regarding our cutting edge new assay for alcohol biomarkers in umbilical cord has been picked up in five languages. It was also picked up by Good Tweets. We are serious about advocating for healthy babies. If you want more information please check out our website:https://www.usdtl.com/.
This week our representatives will have a table at the Chicago Chapter CLMA meeting. Stop by and introduce yourself to our new Forensic Account Executive, Pat Lavelle and pick up more information about our new test.
- Identifying the Indiscernible Isotonitazene (iso)
- Gabapentin, An Emerging Threat in Today’s Opioid Epidemic
- What We Know About CBD
- Kratom Abuse – an Analytical Study on Kratom calls to Poison Control Centers from 2011-2017
- Kratom and its Controversial Threat to Public Health
- Gabapentin Abuse
- USDTL’s Aileen Baldwin Coauthors Recent Studies of Prenatal Alcohol Exposure
- The Development of Alcohol Use Disorder: The Overlooked Epidemic